Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia

ClinicalTrials.gov ID: NCT04372186

Public ClinicalTrials.gov record NCT04372186. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 7:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study (EMPACTA) will a) evaluate the efficacy and safety of tocilizumab (TCZ) compared with a placebo in combination with standard of care (SOC) in hospitalized participants with COVID-19 pneumonia, and b) include an optional long-term extension for eligible participants to explore the long-term sequelae of resolved COVID-19 pneumonia.

Study identification

NCT ID
NCT04372186
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genentech, Inc.
Industry
Enrollment
377 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 13, 2020
Primary completion
Aug 17, 2020
Completion
Sep 21, 2020
Last update posted
Feb 9, 2023

2020

United States locations

U.S. sites
32
U.S. states
14
U.S. cities
31
Facility City State ZIP Site status
Banner - University Medical Center Phoenix; In-Patient Pharmacy Phoenix Arizona 85006
Univ of AZ Coll of Med Tucson Arizona 85724
El Centro Regional Medical Center El Centro California 92243
eStudySite La Mesa California 91942
Highland Hospital Oakland Oakland California 94602
St. Joseph'S Hospital Orange California 92563
San Leandro Hospital; Inpatient Pharmacy San Leandro California 94578
Larkin Community Hospital Palm Springs Campus (Hialeah) Hialeah Florida 33012
Miami Veterans Administration Healthcare System - NAVREF Miami Florida 33125
University of Miami Pulmonary Miami Florida 33125
Larkin Community Hospital South Miami Florida 33143
St. Lukes Boise Medical Center Boise Idaho 83712
Ochsner Clinic New Orleans Louisiana 70121
Holy Cross Germantown Hospital Germantown Maryland 20876
Holy Cross Hospital Silver Spring Maryland 20910
Henry Ford Health System Detroit Michigan 48202
St. Joseph'S Regional Medical Center Paterson New Jersey 07503
San Juan Oncology Associates Farmington New Mexico 87401
SUNY Downstate Medical Center. Brooklyn New York 11203
Elmhurst Hospital Center Elmhurst New York 11373
Flushing Hospital Flushing New York 11355
Jamaica Hospital Medical Center Jamaica New York 11418
Harlem Hospital New York New York 10037
Canton-Potsdam Hospital Potsdam New York 13676
St. Barnabas Hospital The Bronx New York 10457
Novant Health Presbyterian Medical Center (Presbyterian Hospital) Charlotte North Carolina 28204
Cape Fear Valley Medical Center Fayetteville North Carolina 28304
Temple University Hospital Philadelphia Pennsylvania 19140
Valley Baptist Medical Center Harlingen Texas 78550
Michael E Debakey VA Medical Center Houston Texas 77030
McAllen Medical Center McAllen Texas 78503
Sentara Medical Group Virginia Beach Virginia 23462

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04372186, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 9, 2023 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04372186 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →